BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28828728)

  • 21. [Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].
    Bîrlă R; Iosif C; Mocanu A; Gîndea C; Hoară P; Panaitescu E; Constantinoiu S
    Chirurgia (Bucur); 2008; 103(6):635-42. PubMed ID: 19274907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of recurrence in adenocarcinoma of the esophagogastric junction: a retrospective study.
    Xu H; Zhang L; Miao J; Liu S; Liu H; Jia T; Zhang Q
    World J Surg Oncol; 2020 Jun; 18(1):144. PubMed ID: 32593312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mediastinal lymph node metastasis and recurrence in adenocarcinoma of the esophagogastric junction.
    Kurokawa Y; Hiki N; Yoshikawa T; Kishi K; Ito Y; Ohi M; Wada N; Takiguchi S; Mine S; Hasegawa S; Matsuda T; Takeuchi H
    Surgery; 2015 Mar; 157(3):551-5. PubMed ID: 25532434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New evidence guiding extent of lymphadenectomy for esophagogastric junction tumor: Application of Ber-Ep4 Joint with CD44v6 staining on the detection of lower mediastinal lymph node micrometastasis and survival analysis.
    Zheng B; Ni CH; Chen H; Wu WD; Guo ZH; Zhu Y; Zheng W; Chen C
    Medicine (Baltimore); 2017 Apr; 96(14):e6533. PubMed ID: 28383418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenocarcinoma of the esophagogastric junction in Japan.
    Yamamoto M; Baba H; Egashira A; Oki E; Ikebe M; Kakeji Y; Maehara Y
    Hepatogastroenterology; 2008; 55(81):103-7. PubMed ID: 18507087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spleen-preserving lymphadenectomy versus splenectomy in laparoscopic total gastrectomy for advanced gastric cancer.
    Son SY; Shin DJ; Park YS; Oo AM; Jung DH; Lee CM; Ahn SH; Park DJ; Kim HH
    Surg Oncol; 2017 Jun; 26(2):207-211. PubMed ID: 28577727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Outcome of Proximal Gastrectomy for Upper-Third Advanced Gastric and Siewert Type II Esophagogastric Junction Cancer Compared With Total Gastrectomy: A Propensity Score-Matched Analysis.
    Lee S; Chae YS; Yun WG; Kim JC; Park JK; Kim MG; Kim J; Cho YS; Kong SH; Park DJ; Lee HJ; Yang HK
    Ann Surg Oncol; 2024 May; 31(5):3024-3030. PubMed ID: 38372863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of the length of proximal margin on the prognosis in adenocarcinoma of gastroesophageal junction: A real-world study and strategies.
    Pang T; Nie MM; Fan L; Wang JY; Liu ZR; Qin Y; Yin K
    Asian J Surg; 2024 Jun; 47(6):2613-2622. PubMed ID: 38565445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation.
    Gu Y; Swisher SG; Ajani JA; Correa AM; Hofstetter WL; Liao Z; Komaki RR; Rashid A; Hamilton SR; Wu TT
    Cancer; 2006 Mar; 106(5):1017-25. PubMed ID: 16456809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy evaluation of laparoscopy-assisted surgery for Siewert I adenocarcinoma of the esophagogastric junction].
    Fang W; Chen Y; Zhu K
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 May; 17(5):476-9. PubMed ID: 24859959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Optimal surgical approach for esophagogastric junction carcinoma].
    Yamashita H; Seto Y
    Nihon Geka Gakkai Zasshi; 2015 Jan; 116(1):40-4. PubMed ID: 25842812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.
    Mine S; Kurokawa Y; Takeuchi H; Kishi K; Ito Y; Ohi M; Matsuda T; Hamakawa T; Hasegawa S; Yoshikawa T; Hiki N
    Eur J Surg Oncol; 2015 Oct; 41(10):1348-53. PubMed ID: 26087995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Subtotal esophagectomy with stomach transposition as standard operation for adenocarcinoma of the esophagogastric junction].
    Fass J; Dreuw B; Ophoff K; Schumpelick V
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():166-8. PubMed ID: 9101820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical therapy of adenocarcinoma of the esophagogastric junction: analysis of prognostic factors.
    Di Martino N; Izzo G; Cosenza A; Cerullo G; Torelli F; Monaco L; Basciotti A; del Genio A
    Hepatogastroenterology; 2005; 52(64):1110-5. PubMed ID: 16001641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment results of adenocarcinoma of the gastroesophageal junction.
    Yonemura Y; Kojima N; Kawamura T; Tsukiyama G; Bandou E; Sakamoto N; Tsubosa Y; Sato H
    Hepatogastroenterology; 2008; 55(82-83):475-81. PubMed ID: 18613391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in prognosis of Siewert II and III oesophagogastric junction cancers are determined by the baseline tumour staging but not its anatomical location.
    Kulig P; Sierzega M; Pach R; Kolodziejczyk P; Kulig J;
    Eur J Surg Oncol; 2016 Aug; 42(8):1215-21. PubMed ID: 27241921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach.
    Zhu GL; Sun Z; Wang ZN; Xu YY; Huang BJ; Xu Y; Zhu Z; Xu HM
    J Surg Oncol; 2012 Jun; 105(8):786-92. PubMed ID: 22105768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of lower mediastinal lymphadenectomy for the treatment of esophagogastric junction carcinoma.
    Hosoda K; Yamashita K; Katada N; Moriya H; Mieno H; Sakuramoto S; Kikuchi S; Watanabe M
    Anticancer Res; 2015 Jan; 35(1):445-56. PubMed ID: 25550586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pattern of recurrence after surgery in adenocarcinoma of the gastro-oesophageal junction.
    de Manzoni G; Pedrazzani C; Pasini F; Durante E; Gabbani M; Grandinetti A; Guglielmi A; Griso C; Cordiano C
    Eur J Surg Oncol; 2003 Aug; 29(6):506-10. PubMed ID: 12875856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Should the splenic hilar lymph node be dissected for the management of adenocarcinoma of the esophagogastric junction?
    Kumazu Y; Hasegawa S; Hayashi T; Yamada T; Watanabe H; Hara K; Shimoda Y; Nakazono M; Nagasawa S; Rino Y; Masuda M; Ogata T; Oshima T; Yoshikawa T
    Eur J Surg Oncol; 2023 Jan; 49(1):76-82. PubMed ID: 35868951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.